CANCER
Hereditary cancer syndromes account for approximately 5% to 10% of all cases.1, 2
A third of patients with high-risk variants could optimize their treatment after undergoing a genetic test for NGS.
The clinical utility of genetic testing
  • Personalized patient treatment.
  • Predict response to drug therapies and shorten treatment delay times.
  • Consider risk-reducing surgery.
  • Prevent family risk.



Find The Right Test
  • Breast cancer
  • Lung cancer
  • Prostate cancer
  • Pancreatic cancer
  • Colorectal cancer
  • Urinary tract cancer
  • Pediatric oncology
Don’t see what you need on the list? Contact Us.
We design a test for you at no extra cost.






1. Tsaousis, G. N., Papadopoulou, E., et al. (2019). Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations. BMC cancer, 19(1), 535. https://doi.org/10.1186/s12885-019-5756-4
2. Samadder, N. J., Riegert-Johnson, D., et al. (2021). Comparison of Universal Genetic Testing vs Guideline-Directed Targeted Testing for Patients With Hereditary Cancer Syndrome. JAMA oncology, 7(2), 230–237. https://doi.org/10.1001/jamaoncol.2020.6252